Document Download
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial
Author / Organization: David P Carbone, Tudor-Eliade Ciuleanu, Michael Schenker, Manuel Cobo, Stéphanie Bordenave, Oscar Juan-Vidal, Juliana Menezes, Niels Reinmuth, Eduardo Richardet, Ying Cheng, Hideaki Mizutani, Enriqueta Felip, Bogdan Zurawski, Aurelia Alexandru, Luis Paz-Ares, Shun Lu, Thomas John, Xiaoqing Zhang, Javed Mahmood, Nan Hu, Tuli De, Irene Santi, John R Penrod, Yong Yuan, Adam Lee, Martin Reck
| File Format | PDF (Portable Document Format) |
|---|---|
| Publication Year | 2024 |
| Source Host |
HAL Open Science
(hal.science)
|
| License / Terms | Open Access / Creative Commons |
Ready for Immediate Access
Your selected document is ready for instant access with zero mandatory waiting period.
Alternative Options:
Download via MainReads Proxy
Read Online in PDF.js Viewer
Open Source Website »
Linking & Access Policy: MainReads provides direct outbound links to documents and educational resources hosted by original source repositories, universities, and open libraries. Downloads are never made conditional on advertisements or user registrations. If you encounter an inaccessible or broken resource link, please use the Report Broken Link feature on the catalog page.